<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02875730</url>
  </required_header>
  <id_info>
    <org_study_id>16-044</org_study_id>
    <nct_id>NCT02875730</nct_id>
  </id_info>
  <brief_title>A Pilot Investigation Detecting Cryoablation Scar by 3D Late Gadolinium Enhancement</brief_title>
  <acronym>LAMDE</acronym>
  <official_title>A Pilot Investigation Detecting Cryoablation Scar by 3D Late Gadolinium</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aspire Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aspire Foundation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective trial investigating the effectiveness of a modified MRI preparatory
      pulse sequence to improve pulmonary vein isolation visualization.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 13, 2016</start_date>
  <completion_date type="Actual">April 27, 2018</completion_date>
  <primary_completion_date type="Actual">March 6, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Pool Corrected Signal Intensity</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Imaging Failure Rate</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Extent of Detected LGE Signal Correlate to the Respiratory Navigator Scheme</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Cryoablation</condition>
  <arm_group>
    <arm_group_label>CMRI Pulse Sequence</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will have late gadolinium cardiac magnetic resonance images of the individual pulmonary veins acquired with the standard and the cylindrical navigator preparatory pulse sequences for comparison.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pulse Sequence</intervention_name>
    <description>Cylindrical Navigator Preparatory Pulse Sequence</description>
    <arm_group_label>CMRI Pulse Sequence</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CMRI</intervention_name>
    <description>Cardiac Magnetic Resonance Imaging</description>
    <arm_group_label>CMRI Pulse Sequence</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men or non-pregnant women

          -  A diagnosis of symptomatic paroxysmal or recently persistent atrial fibrillation with
             a documented successful cardioversion within 4 months of the procedure

          -  Documented treatment failure or intolerance of at least 1 anti-arrhythmic medication
             used to control atrial fibrillation.

        Exclusion Criteria:

          -  Contraindication to MRI, such as implanted incompatible metal prosthesis, or subject
             size exceeds bore or table limits

          -  Allergy to gadolinium-based contrast agent

          -  Previous atrial fibrillation ablation

          -  Renal dysfunction (estimated GFR &lt;60 mL/min/1.73m2) within 6 months

          -  Unwilling to provide informed consent for this protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Saint Luke's Health System</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>August 16, 2016</study_first_submitted>
  <study_first_submitted_qc>August 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 23, 2016</study_first_posted>
  <last_update_submitted>June 27, 2018</last_update_submitted>
  <last_update_submitted_qc>June 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>August 20, 2018</submitted>
    <returned>January 25, 2019</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

